What is BIOLASE?
BIOLASE, Inc. is a global leader in the development, manufacturing, marketing, and sale of advanced laser systems designed for dental practitioners and their patients. Headquartered in Foothill Ranch, California, the company offers a comprehensive suite of minimally invasive dental solutions, including systems for cosmetic, restorative, and complex surgical applications. Their product portfolio features Waterlase all-tissue dental lasers, diode soft-tissue lasers, and the Epic Hygiene laser, alongside consumable products and accessories. BIOLASE's innovative technology empowers dental specialists to perform a wide array of procedures with enhanced precision and patient comfort, positioning it as a key player in the dental technology market.
How much funding has BIOLASE raised?
BIOLASE has raised a total of $89.5M across 9 funding rounds:
Debt
$8M
Share Placement
$5M
Share Placement
$35M
Share Placement
$10M
Share Placement
$12M
Debt
$6M
Stock Offering
$8.5M
Debt
$3M
Debt
$2M
Debt (2012): $8M with participation from Comerica
Share Placement (2014): $5M led by Oracle Partners L.P
Share Placement (2014): $35M supported by Camber Capital Management, LLC, Jack W. Schuler Living Trust, Eagle Growth Partners I and II, Birchview Capital L.P., Trellus Partners, and Oracle Partners, L.P.
Share Placement (2016): $10M featuring Oracle Partners L.P. and Jack W. Schuler Living Trust
Share Placement (2017): $12M backed by Oracle Investment Management and Jack W. Schuler
Debt (2018): $6M with participation from Bridge Bank
Stock Issuance/Offering (2019): $8.5M, investors not publicly disclosed
Debt (2019): $3M supported by Pacific Mercantile Bank
Debt (2020): $2M featuring PPP
Key Investors in BIOLASE
Camber Capital Management, LLC
Camber Capital Management, LLC is an investment firm that likely focuses on strategic investments within the healthcare and technology sectors, potentially specializing in companies with innovative medical devices or therapeutic solutions.
Jack W. Schuler Living Trust
The Jack W. Schuler Living Trust represents a significant investor, likely with a long-term perspective and a focus on companies demonstrating strong growth potential and market leadership, particularly within the medical technology space.
Pacific Mercantile Bank
Pacific Mercantile Bank is a commercial bank providing financial products and services to businesses, suggesting their investment in BIOLASE may be part of a broader strategy to support innovative companies within their service regions or specific industries.
What's next for BIOLASE?
The substantial enterprise-level funding and strategic investment indicate BIOLASE is poised for significant growth and innovation. This capital infusion will likely fuel further research and development into next-generation dental laser technologies, expand manufacturing capabilities, and enhance global distribution networks. The company's focus on minimally invasive procedures aligns with evolving patient and practitioner preferences, suggesting a strategic direction towards market leadership and increased adoption of its advanced dental solutions. Future endeavors may include strategic partnerships, market penetration in underserved regions, and continued product line expansion to address a broader spectrum of dental needs.
See full BIOLASE company page
